Toronto Dominion Bank lowered its stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 24.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,075,085 shares of the company's stock after selling 342,057 shares during the quarter. Toronto Dominion Bank's holdings in Procter & Gamble were worth $180,232,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. NewSquare Capital LLC increased its holdings in shares of Procter & Gamble by 933.3% in the fourth quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after purchasing an additional 140 shares during the period. Navigoe LLC purchased a new stake in Procter & Gamble in the fourth quarter valued at approximately $31,000. Hoey Investments Inc. increased its holdings in Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after buying an additional 148 shares during the period. LFA Lugano Financial Advisors SA purchased a new position in Procter & Gamble during the 4th quarter worth approximately $34,000. Finally, 10Elms LLP acquired a new stake in Procter & Gamble during the 4th quarter valued at approximately $34,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
Shares of NYSE PG traded up $1.16 during trading on Friday, hitting $169.72. The company had a trading volume of 2,924,186 shares, compared to its average volume of 7,272,863. The firm has a market capitalization of $397.91 billion, a price-to-earnings ratio of 27.04, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The stock has a fifty day simple moving average of $164.21 and a two-hundred day simple moving average of $167.36. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a fifty-two week low of $156.58 and a fifty-two week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The company had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. During the same period in the previous year, the firm posted $1.52 EPS. Procter & Gamble's revenue was down 2.1% compared to the same quarter last year. On average, research analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were issued a $1.0568 dividend. The ex-dividend date of this dividend was Monday, April 21st. This represents a $4.23 dividend on an annualized basis and a yield of 2.49%. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's dividend payout ratio (DPR) is presently 66.98%.
Analyst Upgrades and Downgrades
PG has been the topic of a number of research reports. Citigroup cut their price objective on shares of Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Raymond James cut their price target on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research report on Friday, April 25th. Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. Truist Financial lowered their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Finally, Piper Sandler raised their target price on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a report on Monday, May 5th. Eight analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $178.52.
Read Our Latest Stock Report on PG
Insiders Place Their Bets
In other news, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the transaction, the chief executive officer now directly owns 51,965 shares in the company, valued at $8,386,111.70. The trade was a 1.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the sale, the insider now directly owns 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by corporate insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.